Sankt Görans sjukhus är ett akutsjukhus som ligger vid Sankt Göransgatan på Kungsholmen i Stockholms innerstad. Sjukhuset drivs av ett aktiebolag som ägs av vårdkoncernen Capio.

During the past decade, Capio S:t Görans Hospital conducted 27 clinical trials. In the 10-year time frame, 27 clinical trials started and 4 clinical trials were completed, i.e. on average, 14.8% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 2 clinical trials were completed. i.e. 16.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Capio S:t Görans Hospital" #1 sponsor was "Karolinska Institutet" with 8 trials, followed by "Karolinska University Hospital" with 3 trials sponsored, "Anna Martling" with 2 trials sponsored, "Pfizer's Upjohn has merged with Mylan to form Viatris Inc." with 2 trials sponsored and "Anders Svenningsson" with 2 trials sponsored. Other sponsors include 16 different institutions and companies that sponsored additional 26 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Capio S:t Görans Hospital" #1 collaborator was "Uppsala University" with 5 trials as a collaborator, "Karolinska Institutet" with 4 trials as a collaborator, "The Swedish Research Council" with 3 trials as a collaborator, "Centrallasarettet Västerås" with 2 trials as a collaborator and "Danderyd Hospital" with 2 trials as a collaborator. Other collaborators include 33 different institutions and companies that were collaborators in the rest 42 trials.

According to Clinical.Site data, the most researched conditions in "Capio S:t Görans Hospital" are "Breast Cancer" (4 trials), "Colorectal Cancer" (2 trials), "Multiple Sclerosis, Relapsing-Remitting" (2 trials), "Acute Ischaemic Stroke" (1 trials) and "Acute Myocardial Infarction" (1 trials). Many other conditions were trialed in "Capio S:t Görans Hospital" in a lesser frequency.

Most popular intervention types in "Capio S:t Görans Hospital" are "Drug" (17 trials), "Procedure" (8 trials), "Other" (6 trials), "Device" (4 trials) and "Diagnostic Test" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Carboplatin" (2 trials), "Omission of axillary clearance" (2 trials), "Paclitaxel" (2 trials) and "Rituximab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Capio S:t Görans Hospital" are 29 trials for "All" genders, 4 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Capio S:t Görans Hospital". undefined are not yet recruiting, 11 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 16 completed trials in Capio S:t Görans Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Capio S:t Görans Hospital, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 16 trials that are defined as “Not Applicable".